Ceftaroline Fosamil Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ceftaroline fosamil is a novel broad-spectrum cephalosporin approved by the EMA in 2012 for the treatment of adults with complicated skin and soft-tissue infections (cSSTIs) and community-acquired pneumonia (CAP) [18].Ceftaroline Fosamil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceftaroline Fosamil Nitroso Impurity 1 CAS NO:NA chemically represented as (Z)-2-(2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetamido)-2-(5-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-3-nitroso-3,6-dihydro-2H-1,3-thiazin-2-yl)acetate . Synchemia is the leading manufacturing and exporter of Ceftaroline Fosamil Nitroso Impurity 1 . We supply Ceftaroline Fosamil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014518 |
| CAS No | NA |
| Mol.F. | C12H12N2O4 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014519 |
| CAS No | NA |
| Mol.F. | C7H8N3O5S : Na |
| Mol.Wt. | 246.2 : 23.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014520 |
| CAS No | NA |
| Mol.F. | C14H11ClN3O6S : Na |
| Mol.Wt. | 384.8 : 23.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014521 |
| CAS No | NA |
| Mol.F. | C16H20N4O3 |
| Mol.Wt. | 316.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014522 |
| CAS No | NA |
| Mol.F. | C12H20N2O |
| Mol.Wt. | 208.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014523 |
| CAS No | 2892260-30-7 |
| Mol.F. | C12H7ClN2OS |
| Mol.Wt. | 262.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014524 |
| CAS No | 56516-72-4 |
| Mol.F. | C3H7N2O6P |
| Mol.Wt. | 198.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014525 |
| CAS No | NA |
| Mol.F. | C15H16FN5O3 |
| Mol.Wt. | 333.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014526 |
| CAS No | 55855-43-1 |
| Mol.F. | C16H18N2O2 |
| Mol.Wt. | 270.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014527 |
| CAS No | NA |
| Mol.F. | C19H21F2N5O4 |
| Mol.Wt. | 421.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014528 |
| CAS No | NA |
| Mol.F. | C22H18N4O5 |
| Mol.Wt. | 418.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014529 |
| CAS No | NA |
| Mol.F. | C9H7ClN6OS |
| Mol.Wt. | 282.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014530 |
| CAS No | NA |
| Mol.F. | C5H4N6O2 |
| Mol.Wt. | 180.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014531 |
| CAS No | NA |
| Mol.F. | C21H21N7O2 |
| Mol.Wt. | 403.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014532 |
| CAS No | NA |
| Mol.F. | C17H21N5O2 |
| Mol.Wt. | 327.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014533 |
| CAS No | NA |
| Mol.F. | C22H16FN9O3 |
| Mol.Wt. | 473.4 |
| INV STATUS | CUSTOM SYNTHESIS |